title: [The 4-week prevalence of somatoform disorders and associated psychosocial impairment].
abstract: In the course of a WHO study,we report on the prevalence of somatoform disorders (SFD) and the associated psychosocial impairment in five western German primary care settings. In accordance with ICD-10 classification, a 4-week prevalence of 28.5% was found for SFD (number of patients in the age between 18 and 60 with an SFD in the last 28 days). The accumulation of SFD was higher in female patients than in males (RR 1.7), in particular when the number of children was >1 (RR 1.8). The female-male difference was more marked in persistent somatoform pain disorder (RR 2.1) and unspecific somatization disorder (RR 5.0). Concerning other psychiatric disorders, neurasthenia occurred most frequently,with a 4-week prevalence of 8.2%. The 4-week prevalence of concomitant occurrence of SFD and other psychiatric disorders was 7.7%. Working capability was most severely impaired, with 22.5 days of absence from work during the last month, in male patients with hypochondriacal disorder. In comparison, somatization disorder resulted in a severe level of psychosocial impairment, with 10.3 days of absence in work during the last month in female patients. The coexistence of SFS with other psychiatric disorders resulted in a greater extent of psychosocial impairment.
authors.affiliation: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Bonn. heun@uni-bonn.de
authors.forename: D
authors.initials: D
authors.lastname: Schoepf
authors.forename: R
authors.initials: R
authors.lastname: Heun
authors.forename: O
authors.initials: O
authors.lastname: Weiffenbach
authors.forename: S
authors.initials: S
authors.lastname: Herrmann
authors.forename: W
authors.initials: W
authors.lastname: Maier
mesh_terms: D000293:Adolescent; D000328:Adult; D015897:Comorbidity; D003430:Cross-Sectional Studies; D005260:Female; D005858:Germany / Q000453:epidemiology; D006306:Health Surveys; D006801:Humans; D006998:Hypochondriasis / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology; D015994:Incidence; D038801:International Classification of Diseases; D008297:Male; D001523:Mental Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology; D008875:Middle Aged; D009440:Neurasthenia / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology; D011320:Primary Health Care / Q000706:statistics & numerical data; D011602:Psychophysiologic Disorders / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology; D012307:Risk Factors; D012737:Sex Factors; D012917:Social Adjustment; D013001:Somatoform Disorders / Q000175:diagnosis / Q000453:epidemiology* / Q000523:psychology; D014944:World Health Organization